Table 4.
Laboratory, electrophysiologic, radiographic, and clinical findings of MG in myositis-MG patients.
| Patient | AChR Ab | MuSK Ab | SFEMG | RNS | Thymic hyperplasia* | Pyridostigmine response# | Worse with steroids |
|---|---|---|---|---|---|---|---|
| 1 | + | Not done | Not done | Abnl | − | + | + |
| 2 | − | - | Abnl | Normal | + | + | − |
| 3 | + | Not done | Abnl | Not done | − | − | − |
| 4 | − | - | Normal | Abnl | + | + | + |
| 5 | + | - | Not done | Abnl | − | + | − |
| 6 | + | Not done | Not done | Abnl | − | + | − |
Ab = antibody, Abnl =abnormal, “−” = negative or symptom not reported, “+” = positive or symptom present
determined by chest CT scan.
defined as an immediate (within hours of administration) but transient improvement with pyridostigmine.